financetom
Business
financetom
/
Business
/
Nvidia hits record high as analyst predicts AI 'Golden Wave'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvidia hits record high as analyst predicts AI 'Golden Wave'
Jun 25, 2025 1:11 PM

(Reuters) -Nvidia's ( NVDA ) stock hit a record high on Wednesday, and the chipmaker reclaimed the crown as the world's most valuable company after an analyst said the chipmaker was set to ride a "Golden Wave" of artificial intelligence.

Shares of the Santa Clara, California-based company rose over 4% to a record high of $154.10. The rise sent Nvidia's ( NVDA ) stock market value to $3.76 trillion, overtaking Microsoft ( MSFT ), which was last valued at $3.65 trillion following a 0.2% increase in its stock.

Fueling Nvidia's ( NVDA ) latest rally, Loop Capital lifted its price target for the designer of high-end AI processors to $250 from $175, while maintaining its "buy" rating. 

"Our work suggests we are entering the next 'Golden Wave' of Gen AI adoption and NVDA is at the front-end of another material leg of stronger than anticipated demand," Loop Capital analyst Ananda Baruah wrote in a client note.

Nvidia's ( NVDA ) latest gains reflect the U.S. stock market's return to the "AI trade" that fueled massive gains in chip stocks and related technology companies in recent years on optimism about the emerging technology.

Nvidia ( NVDA ) recently traded at about 30 times analysts' expected earnings for the next 12 months, below its average of about 40 over the past five years, according to LSEG data. That relatively modest price-to-earnings valuation reflects steadily increasing earnings estimates that have outpaced Nvidia's ( NVDA ) sizable stock gains.

Nvidia ( NVDA ), Microsoft ( MSFT ) and Apple ( AAPL ) have traded places several times as the world's most valuable company over the past year, with Microsoft ( MSFT ) leading recently after overtaking Nvidia ( NVDA ) in early June.

Apple's ( AAPL ) stock rose 0.4% on Wednesday, putting its value at $3.0 trillion.

Nvidia ( NVDA ) has now rebounded over 60% from its closing low on April 4, when Wall Street was reeling from President Donald Trump's global tariff announcements. U.S. stocks, including Nvidia ( NVDA ), have recovered on expectations the White House will reach trade deals to soften the tariffs.

The S&P 500 technology sector index was last up 0.9% at an all-time high. It has now gained almost 6% in 2025. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta faces $3.6 million fine in Brazil for allowing bogus Havan ads
Meta faces $3.6 million fine in Brazil for allowing bogus Havan ads
Aug 28, 2024
SÃO PAULO, Aug 28 - Meta Platforms ( META ) faces a fine of up to $3.62 million after losing a lawsuit by Brazilian department store chain Havan that accused the social media company of accepting paid advertisements that fraudulently use the retailer's name to deceive consumers. A Santa Catarina state judge ruled on Monday that Meta had 48 hours...
Market Chatter: Ford to Scale Back Diversity, Equity, Inclusion Policies
Market Chatter: Ford to Scale Back Diversity, Equity, Inclusion Policies
Aug 28, 2024
12:02 PM EDT, 08/28/2024 (MT Newswires) -- Ford Motor ( F ) will change its diversity, equity and inclusion policies and end participation in a ranking by an LGBTQ advocacy group, Bloomberg reported Wednesday, citing an internal e-mail by Chief Executive Jim Farley. We are mindful that our employees and customers hold a wide range of beliefs, Farley said in...
GSK Says Nucala Approved in Japan to Treat Chronic Rhinosinusitis With Nasal Polyps
GSK Says Nucala Approved in Japan to Treat Chronic Rhinosinusitis With Nasal Polyps
Aug 28, 2024
07:25 AM EDT, 08/28/2024 (MT Newswires) -- GSK (GSK) said Wednesday that Japan's Ministry of Health, Labor and Welfare had approved Nucala, or mepolizumab, to treat chronic rhinosinusitis with nasal polyps in adults. The approval is based on phase 3 trial data and supported by the results of a global study, GSK said. Mepolizumab is also approved in Japan for...
Infosys Joins Stanford HAI Corporate Affiliate Program to Speed Up AI Research Initiatives
Infosys Joins Stanford HAI Corporate Affiliate Program to Speed Up AI Research Initiatives
Aug 28, 2024
07:22 AM EDT, 08/28/2024 (MT Newswires) -- Infosys ( INFY ) said Wednesday that it has joined the Stanford University Institute for Human-Centered Artificial Intelligence, or Stanford HAI, corporate affiliate program. The company said the partnership aims to speed up artificial intelligence initiatives. Infosys ( INFY ) said it will discuss themes such as responsible AI, the use of AI...
Copyright 2023-2026 - www.financetom.com All Rights Reserved